Bajaj Healthcare Ltd (BAJAJHCARE) — FY26 Annual Report | 29 August 2026 (2 announcements)

Bajaj Healthcare Limited announced its 33rd AGM scheduled for September 21, 2026, via video conferencing, and dispatched the FY 2025-26 Annual Report. The report highlights 12.6% revenue growth to ₹611.03 Cr, 35.1% PBT growth, and a 0.47 debt-equity ratio, reflecting strategic expansion from APIs to formulations and oncology. Key risks include regulatory and market competition, mitigated through quality investments and R&D. Shareholders will vote on director reappointments, dividend approval, and remuneration, with e-voting from September 17-20, 2026.

Bajaj Healthcare informed shareholders that the Annual Report 2025-26 is accessible via a web link for those who did not register their email addresses, and reminded them to update KYC details and dematerialise physical shares before the AGM on September 21, 2026.